Canada Life’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$380M Buy
1,742,412
+18,234
+1% +$4.04M 0.68% 22
2025
Q4
$394M Sell
1,724,178
-202,628
-11% -$46.2M 0.69% 22
2025
Q3
$430M Buy
1,926,806
+96,062
+5% +$19.6M 0.62% 23
2025
Q2
$340M Sell
1,830,744
-55,156
-3% -$10.3M 0.54% 28
2025
Q1
$396M Sell
1,885,900
-185,094
-9% -$36M 0.7% 23
2024
Q4
$368M Buy
2,070,994
+43,380
+2% +$7.98M 0.63% 24
2024
Q3
$401M Buy
2,027,614
+39,749
+2% +$7.42M 0.7% 23
2024
Q2
$341M Buy
1,987,865
+112,206
+6% +$18.6M 0.64% 24
2024
Q1
$341M Buy
1,875,659
+10,036
+0.5% +$1.73M 0.69% 21
2023
Q4
$288M Buy
1,865,623
+407,116
+28% +$59.4M 0.63% 25
2023
Q3
$217M Buy
1,458,507
+34,176
+2% +$5.02M 0.52% 32
2023
Q2
$193M Sell
1,424,331
-24,205
-2% -$3.55M 0.46% 40
2023
Q1
$231M Buy
1,448,536
+59,300
+4% +$9.07M 0.57% 28
2022
Q4
$226M Sell
1,389,236
-105,936
-7% -$16.2M 0.59% 27
2022
Q3
$201M Sell
1,495,172
-4,639
-0.3% -$666K 0.57% 28
2022
Q2
$230M Sell
1,499,811
-21,961
-1% -$3.36M 0.61% 27
2022
Q1
$260M Buy
1,521,772
+10,980
+0.7% +$1.59M 0.54% 30
2021
Q4
$204M Sell
1,510,792
-11,800
-0.8% -$1.39M 0.42% 46
2021
Q3
$165M Sell
1,522,592
-12,733
-0.8% -$1.45M 0.38% 51
2021
Q2
$173M Buy
1,535,325
+34,657
+2% +$3.9M 0.39% 49
2021
Q1
$161M Sell
1,500,668
-399,859
-21% -$42.8M 0.39% 48
2020
Q4
$203M Buy
1,900,527
+15,287
+0.8% +$1.47M 0.38% 60
2020
Q3
$165M Buy
1,885,240
+55,059
+3% +$5.18M 0.36% 69
2020
Q2
$179M Buy
1,830,181
+356,830
+24% +$31.4M 0.41% 57
2020
Q1
$113M Buy
1,473,351
+217,542
+17% +$18.5M 0.3% 80
2019
Q4
$110M Sell
1,255,809
-20,910
-2% -$1.74M 0.24% 89
2019
Q3
$96.7M Sell
1,276,719
-207,736
-14% -$14.2M 0.23% 108
2019
Q2
$108M Buy
1,484,455
+108,330
+8% +$8.51M 0.25% 97
2019
Q1
$111M Buy
1,376,125
+161,240
+13% +$13.2M 0.29% 83
2018
Q4
$107M Sell
1,214,885
-123,942
-9% -$10.9M 0.31% 74
2018
Q3
$127M Sell
1,338,827
-118,558
-8% -$11.2M 0.3% 76
2018
Q2
$135M Buy
1,457,385
+66,436
+5% +$6.49M 0.32% 70
2018
Q1
$132M Sell
1,390,949
-68,589
-5% -$7.53M 0.32% 72
2017
Q4
$141M Buy
1,459,538
+38,963
+3% +$3.67M 0.33% 72
2017
Q3
$126M Buy
1,420,575
+7,799
+0.6% +$594K 0.31% 75
2017
Q2
$102M Sell
1,412,776
-229,681
-14% -$15.4M 0.27% 76
2017
Q1
$107M Buy
1,642,457
+9,709
+0.6% +$610K 0.29% 75
2016
Q4
$103M Buy
1,632,748
+121,099
+8% +$7.39M 0.29% 78
2016
Q3
$95.3M Sell
1,511,649
-155,741
-9% -$10.1M 0.28% 82
2016
Q2
$103M Buy
1,667,390
+288,901
+21% +$17.6M 0.31% 74
2016
Q1
$78.6M Buy
1,378,489
+181,653
+15% +$10.1M 0.29% 88
2015
Q4
$70.9M Sell
1,196,836
-130,554
-10% -$7.52M 0.27% 87
2015
Q3
$72.2M Buy
1,327,390
+274,927
+26% +$17.9M 0.28% 83
2015
Q2
$70.6M Sell
1,052,463
-34,535
-3% -$2.25M 0.24% 93
2015
Q1
$63.5M Sell
1,086,998
-192,326
-15% -$11.6M 0.22% 108
2014
Q4
$83.6M Buy
1,279,324
+90,623
+8% +$5.71M 0.28% 89
2014
Q3
$68.8M Buy
1,188,701
+143,746
+14% +$7.98M 0.23% 103
2014
Q2
$58.8M Buy
1,044,955
+53,207
+5% +$2.79M 0.19% 121
2014
Q1
$50.7M Buy
991,748
+53,828
+6% +$2.72M 0.18% 136
2013
Q4
$49.7M Sell
937,920
-66,444
-7% -$3.27M 0.18% 121
2013
Q3
$44.9M Buy
1,004,364
+733,881
+271% +$32.5M 0.18% 122
2013
Q2
$11.2M Buy
+270,483
New +$11.8M 0.07% 203

Other funds holding ABBV

Canada Life's ABBV Position: Q1 2026 in Review

Canada Life increased its AbbVie (ABBV) stake by 1.1% in Q1 2026, buying an estimated $4.04M and bringing the position to 1,742,412 shares worth $380M. The position accounts for 0.68% of the portfolio, ranked #22.

Canada Life first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $430M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Canada Life held 1,742,412 shares of AbbVie worth $380M as of Q1 2026.
  • Canada Life bought 18,234 AbbVie shares in Q1 2026, an estimated $4.04M.
  • AbbVie made up 0.68% of Canada Life's portfolio in Q1 2026, its #22 holding.
  • Canada Life first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Canada Life's AbbVie position peaked at $430M in Q3 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.